COVID-19 Intel Center Plan for Implications Get the Facts: Listen to Episodes 1–9 COVID-19 Podcast Series COVID-19 Intel CenterManufacturers Must Navigate Evolving State Approaches to Medicaid Drug Benefit ManagementCOVID-19 Intel CenterCOVID-19 CompassCOVID-19 Intel CenterCOVID-19 Guide for Patients and Providers COVID-19 Intel CenterProvider Impact of COVID-19 Recession and Coverage TrendsCOVID-19 Intel CenterCOVID-19 Relief Funding for Healthcare ProvidersCOVID-19 Intel CenterInsights from the Influenza Vaccine Market for COVID-19 VaccinesDrug PricingPodcast: E1 – Specialty Pharmacy Stakeholder Perspectives: Specialty Pharmacy OutlookCOVID-19 Intel CenterPost-COVID-19 Considerations for the Commercial Health Coverage Market“Although influenza disease burden is high, vaccine uptake remains low.”Chloé ChepiginSenior Associate0%of Seniors Have High-Risk Conditions in Counties with the Most COVID-19 CasesCOVID-19 Intel CenterEmergency State Licensing Flexibilities May Improve Provider Access“Coordinating labs, care sites, imaging, and pharmacy are challenges for oncology care.”Lance GradyPractice Director0Physician procedure codes currently eligible for reimbursement via telehealthCOVID-19 Intel CenterWhat’s Next for Telehealth? HITECH May Offer Lessons
